Isotype-specific glycosylation analysis of mouse IgG by LC-MS

Proteomics

Volumn 16, Issue 9, 2016, Pages 1321-1330

  Maresch, Daniel ^a   Altmann, Friedrich ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Glycoproteomics; Ig; IgG isotype; Mouse IgG; N glycolylneuraminic acid

Indexed keywords

GALACTOSE; GLYCAN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; N GLYCOLOYLNEURAMINIC ACID; SIALIC ACID; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; N ACETYLNEURAMINIC ACID; N-GLYCOLYLNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE; PEPTIDE; POLYSACCHARIDE;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; ELUTION; FUCOSYLATION; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEOMICS; TANDEM MASS SPECTROMETRY; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; CLASSIFICATION; GLYCOSYLATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; PEPTIDE MAPPING; SEQUENCE ALIGNMENT;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; GLYCOSYLATION; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; N-ACETYLNEURAMINIC ACID; NEURAMINIC ACIDS; PEPTIDE MAPPING; PEPTIDES; POLYSACCHARIDES; SEQUENCE ALIGNMENT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84963800298     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500367     Document Type: Article

References (37)

1. Irani, V., Guy, A. J., Andrew, D., Beeson, J. G. et al., Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Mol. Immunol. 2015, 67, 171-182.
2. Umana, P., Jean-Mairet, J., Moudry, R., Amstutz, H., Bailey, J. E., Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. 1999, 17, 176-180.
3. Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N. et al., Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc. Natl. Acad. Sci. USA 2011, 108, 20690-20694.
4. Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y. et al., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 2002, 277, 26733-26740.
5. Jefferis, R., Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev. Drug Discov. 2009, 8, 226-234.
6. Bohm, S., Kao, D., Nimmerjahn, F., Sweet and sour: the role of glycosylation for the anti-inflammatory activity of immunoglobulin G. Curr. Top. Microbiol. Immunol. 2014, 382, 393-417.
7. Hayes, J. M., Cosgrave, E. F., Struwe, W. B., Wormald, M. et al., Glycosylation and Fc receptors. Curr. Top. Microbiol. Immunol. 2014, 382, 165-199.
8. Kaneko, Y., Nimmerjahn, F., Ravetch, J. V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006, 313, 670-673.
9. Kodar, K., Stadlmann, J., Klaamas, K., Sergeyev, B., Kurtenkov, O., Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconj. J. 2012, 29, 57-66.
10. Alavi, A., Axford, J. S., Sweet and sour: the impact of sugars on disease. Rheumatology 2008, 47, 760-770.
11. Bondt, A., Selman, M. H., Deelder, A. M., Hazes, J. M. et al., Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J. Proteome Res. 2013, 12, 4522-4531.
12. Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C. A. et al., A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 2014, 123, 471-480.
13. Gardinassi, L. G., Dotz, V., Hipgrave Ederveen, A., de Almeida, R. P. et al., Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation. MBio 2014, 5, e01844.
14. Seeling, M., Hillenhoff, U., David, J. P., Schett, G. et al., Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc. Natl. Acad. Sci. USA 2013, 110, 10729-10734.
15. Michaelsen, T. E., Kolberg, J., Aase, A., Herstad, T. K., Hoiby, E. A., The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis. Scand. J. Immunol. 2004, 59, 34-39.
16. Strait, R. T., Posgai, M. T., Mahler, A., Barasa, N. et al., IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. Nature 2015, 517, 501-504.
17. Nimmerjahn, F., Ravetch, J. V., Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 2005, 310, 1510-1512.
18. Nimmerjahn, F., Bruhns, P., Horiuchi, K., Ravetch, J. V., FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005, 23, 41-51.
19. Martin, R. M., Brady, J. L., Lew, A. M., The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 1998, 212, 187-192.
20. Zhang, Z., Goldschmidt, T., Salter, H., Possible allelic structure of IgG2a and IgG2c in mice. Mol. Immunol. 2012, 50, 169-171.
21. Ehlers, M., Fukuyama, H., McGaha, T. L., Aderem, A., Ravetch, J. V., TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 2006, 203, 553-561.
22. Chen, H. W., Huang, H. W., Hu, H. M., Chung, H. H. et al., A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus. J. Gen. Virol. 2014, 95, 1983-1990.
23. Raju, T. S., Briggs, J. B., Borge, S. M., Jones, A. J., Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 2000, 10, 477-486.
24. Stadlmann, J., Pabst, M., Kolarich, D., Kunert, R., Altmann, F., Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008, 8, 2858-2871.
25. Kolarich, D., Altmann, F., N-Glycan analysis by matrix-assisted laser desorption/ionization mass spectrometry of electrophoretically separated nonmammalian proteins: application to peanut allergen Ara h 1 and olive pollen allergen Ole e 1. Anal. Biochem. 2000, 285, 64-75.
26. Pabst, M., Chang, M., Stadlmann, J., Altmann, F., Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140. Biol. Chem. 2012, 393, 719-730.
27. Abdelmoula, M., Spertini, F., Shibata, T., Gyotoku, Y. et al., IgG3 is the major source of cryoglobulins in mice. J. Immunol. 1989, 143, 526-532.
28. Stavenhagen, K., Hinneburg, H., Thaysen-Andersen, M., Hartmann, L. et al., Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J. Mass Spectrom. 2013, 48, 627-639.
29. Schreier, P. H., Bothwell, A. L., Mueller-Hill, B., Baltimore, D., Multiple differences between the nucleic acid sequences of the IgG2aa and IgG2ab alleles of the mouse. Proc. Natl. Acad. Sci. USA 1981, 78, 4495-4499.
30. Church, D. M., Goodstadt, L., Hillier, L. W., Zody, M. C. et al., Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol. 2009, 7, e1000112.
31. Chung, C. H., Mirakhur, B., Chan, E., Le, Q. T. et al., Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1, 3-galactose. N. Engl. J. Med. 2008, 358, 1109-1117.
32. Lund, J., Takahashi, N., Nakagawa, H., Goodall, M. et al., Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. Mol. Immunol. 1993, 30, 741-748.
33. Mahan, A. E., Tedesco, J., Dionne, K., Baruah, K. et al., A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. J. Immunol. Methods 2015, 417, 34-44.
34. Bakovic, M. P., Selman, M. H., Hoffmann, M., Rudan, I. et al., High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J. Proteome Res. 2013, 12, 821-831.
35. Dereeper, A., Guignon, V., Blanc, G., Audic, S. et al., Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 2008, 36, W465-W469.
36. Castilho, A., Gruber, C., Thader, A., Oostenbrink, C. et al., Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation. MAbs 2015, 7, 863-870.
37. Pabst, M., Bondili, J. S., Stadlmann, J., Mach, L., Altmann, F., Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal. Chem. 2007, 79, 5051-5057.